跳至主要内容
临床试验/NCT07209436
NCT07209436尚未招募不适用

Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction

Amy Colwell1 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2025年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
212
试验地点
1
主要终点
Patient-reported physical well-being and breast symptoms

研究概览

简要总结

The broad aim of this study is to compare the effectiveness of paravertebral and pectoral blocks on pain and physical well-being of patients undergoing immediate implant-based breast reconstruction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patient 18 years or older
  • •Scheduled for unilateral or bilateral immediate implant-based breast reconstruction
  • •Therapeutic or prophylactic indication
  • •Patient understands the study procedures and objectives and is willing to participate
  • •Patient willing to and capable of providing informed consent

排除标准

  • •Delayed breast reconstruction
  • •Allergy or contraindication to local anesthetics (PVB or PECS blocks)
  • •History of radiation therapy
  • •Planned sedation or general anesthesia protocol variation
  • •Morbid obesity as defined as a BMI greater than 40 kg/m2
  • •Renal insufficiency
  • •Chronic pain syndrome or central sensitization disorders (e.g., fibromyalgia, CRPS)
  • •Use of implanted pain devices or neuromodulators
  • •Pre-existing neurological deficits in the surgical field
  • •Current chronic opioid use (daily use within the 2 weeks before surgery and duration of use greater than 4 weeks)
  • •Use of any nerve medications in the past 6 months, including antiepileptic medications (gabapentin, carbamazepine)
  • •History of drug or alcohol abuse or habitual alcohol intake greater than two standard drinks per day (e.g., two beers, two glasses of wine, or two mixed drinks)
  • •Any comorbidity that results in moderate or severe functional limitation, inability to communicate with the investigators or hospital staff
  • •History of a psychiatric disorder which would interfere with the study procedure
  • •Incarceration
  • •Any issue that at the discretion of the investigator would contraindicate the subject's participation
  • •Inability to understand the procedures and objectives of the study
  • •Inability to or unwilling to provide informed consent

研究组 & 干预措施

Paravertebral Block

Active Comparator

Paravertebral block at preop

干预措施: Paravertebral block (single injection) (Procedure)

Pectoral Block

Experimental

Pectoral block at preop

干预措施: Pectoral block (Procedure)

结局指标

主要结局

Patient-reported physical well-being and breast symptoms

时间窗: 12 Months

Patient-reported physical well-being and breast symptoms will be evaluated using the Breast Quality of Life Physical Well-Being and Breast Symptoms scales. Values are scores from 0 to 100, with higher scores indicating better satisfaction or quality of life for patients undergoing breast surgery, such as those with breast cancer. These scores are derived from patient-reported outcome measures across different domains like satisfaction with breasts, psychosocial well-being, physical well-being (chest and abdomen), and sexual well-being.

Brief Pain Inventory (BPI) Scoring

时间窗: 12 Months

The BPI is a self-report questionnaire that assesses pain intensity and interference. It consists of two parts: Pain Severity: Measures the intensity of pain using a 0-10 scale, where 0 is "no pain" and 10 is "worst possible pain." Pain Interference: Measures how much pain interferes with daily activities using a 0-10 scale for seven items (e.g., general activity, mood, sleep). Calculation of Scores: Pain Severity Score: Add up the scores for the four pain severity questions (worst pain, least pain, average pain, current pain) and divide by 4. Pain Interference Score: Add up the scores for the seven pain interference questions and divide by 7. Interpretation: Pain Severity: 0-3: Mild pain 4-6: Moderate pain 7-10: Severe pain Pain Interference: Higher scores indicate greater interference with daily activities.

次要结局

未报告次要终点

研究者

发起方
Amy Colwell
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Amy Colwell

Sponsor-Investigator

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验